Cargando…

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response

BACKGROUND: To determine whether office, home, ambulatory daytime and nighttime blood pressure (BP) responses to antihypertensive drug therapy measure the same signal and which method provides greatest power to identify genetic predictors of BP response. METHODS: We analyzed office, home, ambulatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Stephen T, Schwartz, Gary L, Chapman, Arlene B, Beitelshees, Amber L, Gums, John G, Cooper-DeHoff, Rhonda M, Boerwinkle, Eric, Johnson, Julie A, Bailey, Kent R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342146/ https://www.ncbi.nlm.nih.gov/pubmed/22413836 http://dx.doi.org/10.1186/1479-5876-10-47

Ejemplares similares

Association of Chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
por: Duarte, Julio D., et al.
Publicado: (2012)

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

Genome‐Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β‐Blockers
por: Shahin, Mohamed H., et al.
Publicado: (2018)

Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide
por: Duarte, Julio D, et al.
Publicado: (2012)

Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response
por: Singh, Sonal, et al.
Publicado: (2019)

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers
por: Cunningham, Patrick N., et al.
Publicado: (2019)

Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta‐Blockers in European Americans
por: Singh, Sonal, et al.
Publicado: (2019)

Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics
por: Sá, Ana Caroline C., et al.
Publicado: (2017)

Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
por: Del-Aguila, J L, et al.
Publicado: (2014)

Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
por: Shahin, Mohamed H., et al.
Publicado: (2017)

Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies
por: Sá, Ana Caroline C., et al.
Publicado: (2018)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study
por: McDonough, Caitrin W., et al.
Publicado: (2013)

Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs
por: Hiltunen, Timo P., et al.
Publicado: (2015)

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
por: Mehanna, Mai, et al.
Publicado: (2021)

Genome‐Wide Meta‐Analysis of Blood Pressure Response to β(1)‐Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)
por: Singh, Sonal, et al.
Publicado: (2019)

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
por: Wikoff, William R., et al.
Publicado: (2013)

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients
por: Singh, Sonal, et al.
Publicado: (2018)

Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation?
por: Chang, SW, et al.
Publicado: (2016)

Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients
por: Mehanna, Mai, et al.
Publicado: (2022)

Antihypertensive Drug Class Interactions and Risk for Incident Diabetes: A Nested Case–Control Study
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2013)

Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison
por: McDonough, Caitrin W, et al.
Publicado: (2020)

Impact of CYP2D6 polymorphisms on clinical efficacy & tolerability of metoprolol tartrate
por: Hamadeh, Issam S., et al.
Publicado: (2014)

Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy
por: Gerhard, Tobias, et al.
Publicado: (2012)

Large‐Scale Gene‐Centric Analysis Identifies Polymorphisms for Resistant Hypertension
por: Fontana, Vanessa, et al.
Publicado: (2014)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
por: Smith, Steven M., et al.
Publicado: (2022)

Medication Adherence—Still the Holy Grail
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2023)

Aromatase Gene Polymorphisms Are Associated with Survival among Patients with Cardiovascular Disease in a Sex-Specific Manner
por: Beitelshees, Amber L., et al.
Publicado: (2010)

In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
por: Chamberlain, Alanna M., et al.
Publicado: (2023)

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
por: Rotroff, DM, et al.
Publicado: (2015)

Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes
por: Chang, Shin-Wen, et al.
Publicado: (2016)

Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management
por: Schneider, Thomas M., et al.
Publicado: (2021)

Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension
por: Kardia, Sharon LR, et al.
Publicado: (2007)

Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure
por: Elgendy, Islam Y., et al.
Publicado: (2019)

2246: Characterization of resistant hypertension in a statewide electronic health record-based database (OneFlorida)
por: McDonough, Caitrin W., et al.
Publicado: (2018)

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial
por: Dasa, Osama, et al.
Publicado: (2021)

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals
por: Le, MyPhuong T., et al.
Publicado: (2013)

Effects of Emotional Response on Adherence to Antihypertensive Medication and Blood Pressure Improvement
por: Keeley, Robert D., et al.
Publicado: (2013)

Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension
por: Ghazi, Lama, et al.
Publicado: (2022)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsl6d6n6rai0amta4f3fk9ilis